Market Closed -
Other stock markets
|
Pre-market 05:36:40 pm | |||
820.3 USD | +0.65% | 822 | +0.21% |
01:55pm | Structure Therapeutics' obesity drug meets main goal in mid-stage study | RE |
02:30am | Transcript : Eli Lilly and Company - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.73% | 739B | |
+31.00% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.89% | 240B | |
+9.33% | 210B | |
-5.19% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly and Company's Phase 3 Study of Mirikizumab to Treat Crohn's Disease Achieves 'Meaningful Improvements'